CTOs on the Move

PRA Health Sciences

www.prahs.com

 
At PRA Health Sciences, providing innovative solutions for our clients is what we do. Side by side with our clients, we strive to move drug discovery forward, helping develop life-saving and life-improving drugs. PRA has more than 10,000 employees working in 80+ countries providing comprehensive clinical development services across all phases. From full service clinical development to the pioneering Embedded Solutions model, PRA provides a broad spectrum of solutions that meet the demands of a diverse marketplace. As a top five CRO, we have worked on 100 plus marketed drugs across several therapeutic areas and conducted the pivotal or supportive ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.prahs.com
  • 4130 Parklake Avenue Suite 400
    Raleigh, NC USA 27612
  • Phone: 919.786.8200

Executives

Name Title Contact Details
Mike Whitehead
Associate Director, Cybersecurity Risk Management Profile
Denzil Burriss
Director of IT Profile
Felix Ritscher
PRA Health Sciences Profile

Similar Companies

The Turnaround Team

The Turnaround Team is a Westfield, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Formulife

4x Award Winner WHETHER YOU HAVE AN EXISTING BRAND OR ARE LOOKING TO START UP A NEW LINE, FORMULIFE SUPPLEMENTS HAS THE EXPERIENCE AND FACILITY TO ASSIST YOUR BUSINESS EVERY STEP OF THE WAY.

Mental Health and Mental Retardation Authority of Harris County

Mental Health and Mental Retardation Authority of Harris County is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

IMAC Regeneration Centers

IMAC Regeneration Centers offers long-term solutions for chronic musculoskeletal conditions without surgery or opioids. This state-of-the-art medical treatment utilizes a combination of regenerative medicine and rehabilitation to prevent the most common unnecessary surgeries, including spinal fusion and laminectomy, and knee and hip replacements. Each of these surgeries require an opioid prescription 99.9% of the time, leading to a high risk of addiction and never returning to work.

Synthetic Biologics

Synthetic Biologics, Inc. trades on the NYSE MKT, LLC under the symbol "SYN". The Company`s principal executive offices are located in Rockville, MD, and the finance and administrative office is located in Ann Arbor, MI. Synthetic Biologics, Inc. is a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases. The Company`s lead candidates in Phase 2 development include SYN-004 which is designed to protect the gut microbiome from the effects of certain commonly used intravenous (IV) antibiotics for the prevention of C. difficile infection and antibiotic-associated diarrhea (AAD), and SYN-010 which is intended to reduce the impact of methane producing organisms in the gut microbiome to treat the underlying cause of irritable bowel syndrome with constipation (IBS-C). In addition, the Company is developing a monoclonal antibody combination for the treatment of Pertussis, and a Phase 2 oral estriol drug for the treatment of relapsing-remitting multiple sclerosis (MS) and cognitive dysfunction in MS.